European Medicines Agency Doc. Ref.: EMEA[removed]

First Page		Document Content
Date: 2013-07-21 05:36:38 Electrolyte disturbances Syndromes Diuretics Amides Organochlorides Hyponatremia Syndrome of inappropriate antidiuretic hormone hypersecretion Tolvaptan Vasopressin Medicine Chemistry Health		European Medicines Agency Doc. Ref.: EMEA[removed] Add to Reading List Source URL: www.ema.europa.eu Download Document from Source Website File Size: 48,53 KB Share Document on Facebook

	@2.APR-2@12 18:15 {ffigE*tr DocID: W83X - View Document
	PH ARMACEUTICAL SEGMENT Otsuka-people creating new products for better health worldwide Pharmaceutical Segment Overview DocID: T3F4 - View Document
	Vaptans: A Potential New Approach for Treating Chronic Hyponatremia in Psychotic Patients Translational Neuroscience, LLC Conshohocken, PA[removed]1Department DocID: P8Ei - View Document
	FDA Briefing Document for the Cardiovascular and Renal Drugs Advisory (CRDAC) Meeting Date: 13 September 2012 DocID: EgJl - View Document
	Microsoft PowerPoint - Otsuka_tolvaptan_08[removed]ACM sponsor slides DocID: E7Yb - View Document